Ashish Life Science

What Ashish Life Science does

Ashish Life Science Private Limited, part of the Ashish Group of Industries established in 1975, is an India-based veterinary pharmaceutical manufacturer founded in 2002 and headquartered in Mumbai. The company develops, manufactures, and distributes a broad veterinary product portfolio across three end markets — companion animals (dogs, cats, horses), livestock (cattle, sheep, goats), and poultry — spanning approximately 60+ branded SKUs across anthelmintics, antibiotics, ectoparasiticides, anti-inflammatories, nutritional supplements, and anticoccidials in multiple dosage forms including bolus, tablet, chewable, capsule, oral liquid, oral paste, injectable, pour-on, powder, and spot-on formulations.

Manufacturing is conducted at a WHO GMP-, EU GMP-, and APVMA-certified facility in Tarapur, Palghar (Maharashtra), with reported daily capacity of 3000L for oral liquids and pastes and 2000L for liquid injectables, plus powder/granule production. The facility supports both proprietary branded production and contract manufacturing for national and international pharmaceutical firms. Beyond manufacturing, the company offers CDMO services (formulation development, analytical method validation, ICH-compliant stability studies) and Regulatory Affairs services for client product registrations across multiple jurisdictions.

Ashish Life Science generates revenue through two primary streams: direct sales of branded veterinary pharmaceuticals via a network of international distributors and importers in 55+ countries (the company self-reports exports to 60+ countries), and B2B contract manufacturing and product development services for pharmaceutical firms. Pricing is quote-based and not publicly disclosed. The company is privately held under CIN U24100MH1992PTC064810, with no disclosed external institutional ownership beyond the 2019 funding round led by Eight Roads Ventures, with Anterra Capital and Fidelity International.

Name

Ashish Life Science

Legal name

Ashish Life Science Private Limited

Website

https://ashishlifescience.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

Ashish Life Science is a Mumbai-based veterinary pharmaceutical manufacturer producing branded drugs and contract manufacturing services for livestock, poultry, and companion animals, exporting to 55+ countries from a WHO/EU GMP-certified Tarapur facility.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF)

akta.pro secondary industries

Companion Animal Maintenance & Wellness Nutrition (HLAMAHAB), Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid) (HLAMAEAG)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Contract manufacturing
• Livestock medicines
• Poultry formulations

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Contract Manufacturing Organization (CMO) Services: ALS undertakes CMO business for national and international firms providing tailor-made supplies and one-stop solutions for final product manufacturing. Revenue is generated through manufacturing fees for client-specified products.
2. Product Development Services: Formulation development services, analytical method validation, and stability studies conducted according to ICH guidelines. Revenue generated through milestone-based payments as development progresses.
3. Regulatory Services: Regulatory affairs services including marketing authorization applications, registration dossier compilation, and communication with regulatory authorities. Provided as part of comprehensive client support.
4. Veterinary Product Sales: Direct sales of proprietary veterinary pharmaceutical products across livestock, poultry, and companion animal categories. Products include boluses, tablets, injections, oral liquids, powders, and pour-ons.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Ashish Life Science is a veterinary pharmaceutical manufacturer that develops, produces, and exports a broad range of branded animal health products for livestock, poultry, and companion animals across multiple dosage forms (bolus, tablets, chewables, capsules, oral liquids, pastes, injectables, pour-ons, water-soluble powders/granules, sterile diluents). The company also operates as a Contract Manufacturing Organization (CMO/CDMO), offering end-to-end formulation development, manufacturing, and regulatory affairs services to national and international pharmaceutical firms.

Product overview

Ashish Life Science is a veterinary pharmaceutical manufacturer offering a comprehensive portfolio of veterinary products and contract manufacturing services. The company's product portfolio is organized into three main animal health segments: Companion Animals (dogs and cats), Livestock (cattle, sheep, goats, horses), and Poultry. The companion animal portfolio includes ASHIENRO, ASHIMEDIN, ASHIVER PLUS, AURIMODERM, DIROHEART, DUROTIC, EXFREE, FURNIL, METHIPOWER, NUTRIPOWER, OPTISHELD, and ZEROKRIM CH products. The livestock portfolio features extensive anthelmintic lines (ALBECTIN, ASHIALBEN, ASHITAL, ASHITETRA, ASHIVER, FENACURE, NILZASH, TERAZOLE, TETRACOZASH), antibiotics (ASHOXY, ASHTYL, ASHULPHA, ASTRISUL), ectoparasiticides (ASHIDELTRIN, ASHIMETHRIN, ASHITRAZ, FLUMAX), and support products (ASHIVITA, CALVITAM, CATACURE, MAXIVIT, MELOXICASH). The poultry portfolio includes anticoccidials (ASAMPRO, TOLTRACOX), antibiotics (ASHIDOX, ENROGEN, ASHTYL), supplements (ASHIBOOST, ASHIVITA, CALVITAM EGG, STRESSWIN), and immune support (Ashimmune). Beyond products, the company provides Contract Manufacturing Organization (CMO) services, CDMO services (end-to-end development and manufacturing), Regulatory Affairs services, and Product Development services including formulation development and ICH-compliant stability studies.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing Organization (CMO) Services

Quantifiable outcome

• Exports to over 60 countries worldwide
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• International Distributors and Importers NetworkcoreChannel Partner/ Reseller/ DistributorALS has built relationships with partners, distributors and key retailers in more than 55 countries. These distributors handle local product registration, marketing, and distribution within their territories. ALS supports these partners through their dedicated Regulatory Affairs Department which provides technical documentation, dossiers, and marketing support for registrations and sales strengthening.
• SNV (B2B Program Partner)minorStrategic or Co-development PartnerALS participated in SNV's B2B Program in Hawassa, Ethiopia. SNV is an international development organization that supports partnerships between businesses in the agricultural sector.
• GALVmed (Gates Foundation Partner)minorStrategic or Co-development PartnerALS participated in a brainstorming session hosted by the Gates Foundation and GALVmed in Dubai. GALVmed is a global alliance working to make livestock vaccines accessible and affordable.
• Wallaga University School of Veterinary MedicineminorStrategic or Co-development PartnerALS collaborated with Wallaga University School of Veterinary Medicine for a deworming campaign, demonstrating commitment to veterinary education and animal health awareness.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Sava Healthcare: Indian veterinary pharmaceutical manufacturer with multi-dosage form capabilities and global exports. Direct peer to ALS in being an India-based multi-formulation animal health manufacturer serving regulated and emerging export markets.
• Vetoquinol: France-headquartered global veterinary pharmaceutical manufacturer with a broad portfolio across livestock, poultry, and companion animals. Comparable to ALS in being a non-big-pharma player focused on animal health generics and branded therapeutics across multiple dosage forms and geographies.
• Hester Biosciences: India-based veterinary biologicals and pharmaceutical manufacturer serving livestock and poultry markets globally. Closest Indian peer to ALS given overlapping product types (vaccines, therapeutics, feed supplements) and export-driven business model.
• Phibro Animal Health: US-listed animal health and nutrition company specializing in antibacterials, anticoccidials, and nutritional specialty products for livestock. Comparable to ALS's antibiotic, anticoccidial, and nutritional supplement product lines targeting production animals.
• Alivira Animal Health (now part of Vetoquinol): India-based veterinary pharmaceutical manufacturer acquired by Vetoquinol, historically focused on livestock and poultry APIs and formulations. Direct comparable to ALS in Indian-based manufacturing, API-to-formulation integration, and emerging-market export focus.
• Sequent Scientific: India-based veterinary API and finished dosage manufacturer with global distribution. Highly comparable peer to ALS given shared Indian manufacturing base, generic API + formulation model, and exports to regulated and emerging markets.

Broad incumbents

• Zoetis: World's largest animal health company offering pharmaceuticals, vaccines, diagnostics, and medicated feed additives across species. Comparable end-product categories to ALS but at vastly larger scale and with stronger proprietary vaccine/biologic franchises.
• Dechra Pharmaceuticals: UK-listed global veterinary pharmaceuticals company with strong positions in companion animal therapeutics, endocrinology, and pain management. Comparable to ALS's companion animal portfolio including NSAIDs (meloxicam), cardiac (pimobendan), and ophthalmic (cyclosporin) products.
• Indovet (Zydus Animal Health): Animal health division of Zydus, one of India's largest pharmaceutical groups, manufacturing veterinary formulations and APIs. Comparable to ALS in India-based multi-species veterinary manufacturing with broader parent-group reach and capital base.

Regional players

• Biovet Private Limited: Indian manufacturer of veterinary biologicals and pharmaceuticals focused on livestock and poultry. Comparable product categories to ALS (vaccines, antibiotics, nutritional supplements) with strong domestic India footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xfacebook.com/AshishLifeSciencePvtLimited
• Facebookfacebook.com/AshishLifeSciencePvtLimited
• LinkedInlinkedin.com/company/ashishlifescienceindia
• Instagraminstagram.com/ashish.life.science

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ashish Life Science